National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations... Show more
The RSI Indicator for NRC moved out of oversold territory on August 04, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 35 similar instances when the indicator left oversold territory. In of the 35 cases the stock moved higher. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on August 07, 2025. You may want to consider a long position or call options on NRC as a result. In of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for NRC just turned positive on August 07, 2025. Looking at past instances where NRC's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NRC advanced for three days, in of 303 cases, the price rose further within the following month. The odds of a continued upward trend are .
NRC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
NRC moved below its 50-day moving average on July 16, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for NRC crossed bearishly below the 50-day moving average on July 23, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NRC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for NRC entered a downward trend on August 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.367) is normal, around the industry mean (11.231). P/E Ratio (19.610) is within average values for comparable stocks, (80.335). NRC's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (2.407). Dividend Yield (0.032) settles around the average of (0.063) among similar stocks. P/S Ratio (2.495) is also within normal values, averaging (85.405).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NRC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
a provider of market research services for the healthcare industry
Industry ServicestotheHealthIndustry
A.I.dvisor indicates that over the last year, NRC has been loosely correlated with UPBD. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NRC jumps, then UPBD could also see price increases.
Ticker / NAME | Correlation To NRC | 1D Price Change % | ||
---|---|---|---|---|
NRC | 100% | +2.79% | ||
UPBD - NRC | 47% Loosely correlated | -1.23% | ||
DH - NRC | 43% Loosely correlated | -2.77% | ||
EEFT - NRC | 42% Loosely correlated | +0.42% | ||
DOX - NRC | 42% Loosely correlated | +0.61% | ||
ETWO - NRC | 41% Loosely correlated | N/A | ||
More |
Ticker / NAME | Correlation To NRC | 1D Price Change % |
---|---|---|
NRC | 100% | +2.79% |
Health Services category (442 stocks) | 34% Loosely correlated | +0.88% |
Services to the Health Industry category (97 stocks) | 16% Poorly correlated | +0.84% |